Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
32471
CAS Number:
86639-52-3
7-éthyl-10-hydroxycamptothécine
Purity:
≥ 99 % (HPLC)
Hazmat
Documents
$48.67 /250 mg
Taille
Request Bulk Quote
Product Information

Conserver le récipient bien fermé dans un endroit sec et bien aéré.

CAS Number
86639-52-3
Purity
≥ 99 % (HPLC)
Molecular Formula
C22H20N2O5
Molecular Weight
392.4
MDL Number
MFCD00871873
PubChem ID
4014291
Melting Point
217 ?C
Appearance
Poudre cristalline jaune pâle
Optical Rotation
[a] 20 D = 21,5 ± 2 º (C=0,5 dans DMSO)
Conditions
Conserver à ≤ -10 °C
General Information
CAS Number
86639-52-3
Purity
≥ 99 % (HPLC)
Molecular Formula
C22H20N2O5
Molecular Weight
392.4
MDL Number
MFCD00871873
PubChem ID
4014291
Melting Point
217 ?C
Appearance
Poudre cristalline jaune pâle
Optical Rotation
[a] 20 D = 21,5 ± 2 º (C=0,5 dans DMSO)
Conditions
Conserver à ≤ -10 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Oui
Antibiotic
Non
DEA-regulated
Non
Warnings
-
Applications

7-Ethyl-10-hydroxycamptothecin is widely utilized in research focused on:

  • Cancer Treatment: This compound is being investigated for its potential as an anti-cancer agent, particularly in treating various types of tumors. Its ability to inhibit DNA topoisomerase I makes it a promising candidate in oncology.
  • Pharmaceutical Development: Researchers are exploring its formulation in drug delivery systems, enhancing the bioavailability of cancer therapies. This could lead to more effective treatments with fewer side effects.
  • Combination Therapies: It is being studied in combination with other chemotherapeutic agents to improve treatment efficacy and reduce drug resistance in cancer cells.
  • Biological Research: The compound serves as a valuable tool in cellular and molecular biology studies, helping scientists understand the mechanisms of cancer cell proliferation and apoptosis.
  • Natural Product Synthesis: Its structure inspires synthetic chemists to develop new analogs with improved therapeutic profiles, potentially leading to novel cancer treatments.

Citations